A Phase 2, Open-label Study of Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Phase of Trial: Phase II
Latest Information Update: 09 Jan 2019
At a glance
- Drugs Rucaparib (Primary)
- Indications Bladder cancer; Carcinoma; Ureteral neoplasms; Urethral cancer; Urogenital cancer
- Focus Therapeutic Use
- Acronyms ATLAS
- Sponsors Clovis Oncology
- 23 Oct 2018 Trial design presented at the 43rd European Society for Medical Oncology Congress
- 03 Oct 2018 According to a Clovis Oncology media release, data from the trial will be presented at the 2018 ESMO Congress later this month.
- 05 Jun 2018 Trial design presented at the 54th Annual Meeting of the American Society of Clinical Oncology.